Sex differences in the predictive power of the molecular prognostic factor HER2/neu in patients with non-small-cell lung cancer.
about
Role of HER2 in NSCLCThe potential of gender-specific tumor pharmacology.Current vaccine updates for lung cancer.Gender-specific survival after surgical resection for early stage non-small cell lung cancer.Driver genes in non-small cell lung cancer: Characteristics, detection methods, and targeted therapies.
P2860
Sex differences in the predictive power of the molecular prognostic factor HER2/neu in patients with non-small-cell lung cancer.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Sex differences in the predict ...... th non-small-cell lung cancer.
@en
Sex differences in the predict ...... th non-small-cell lung cancer.
@nl
type
label
Sex differences in the predict ...... th non-small-cell lung cancer.
@en
Sex differences in the predict ...... th non-small-cell lung cancer.
@nl
prefLabel
Sex differences in the predict ...... th non-small-cell lung cancer.
@en
Sex differences in the predict ...... th non-small-cell lung cancer.
@nl
P2093
P356
P1433
P1476
Sex differences in the predict ...... th non-small-cell lung cancer.
@en
P2093
Arnulf H Holscher
Daniel Vallböhmer
Jan Brabender
Kathleen Danenberg
Paul M Schneider
Peter V Danenberg
Ralf Metzger
P304
P356
10.3816/CLC.2006.N.015
P407
P50
P577
2006-03-01T00:00:00Z